Industry Events Dual-carbon Innovations & Startups Competition Find Investors About Us

Sectors

All investors

114 institutional investors

Stage preference

Types of funds

Raked by

Qiming VC

Investments: 671

Funds: 26

Qiming Venture Partners is a top-tier VC firm with outstanding reputation. With our exceptional investment performances, we have been widely recognized by investors from around the world. We have a reputation for being entrepreneur friendly.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.4 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages. Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi , Meituan, Bilibili, Zhihu, Roborock, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, New Horizon Health, Venus MedTech, Sanyou Medical, AmoyDx， Berry Genomics, SinocellTech, Yuanxin Technology, dMed-Clinipace, Belief BioMed, WeRide, Biren Technology and UBTech among many others.

Shanghai
Tsinghua Holding Capital

Investments: 80

Funds: 18

Established in 2007, Tsinghua Holdings Capital has a series of VC, PE, industrial funds, M&A funds, overseas funds, and more than 20 sub-funds including general aviation, military industry investment funds invested in different stages and different professional fields, with a management scale of over 10 billion yuan. It is committed to becoming the best private equity investment institution in China and focusing on investing in leading enterprises in sub-sectors, with an emphasis on industries in high-speed development such as advanced manufacturing and high-end equipment, new generation information technology, carbon neutrality and biotechnology. Tsinghua Holdings Capital insists on investment with industrial thinking, selects high-growth enterprises to invest in through in-depth and solid industry research (TOP-DOWN mode), and reduces risks through strict risk control systems. Invested enterprises include Guanglian Aviation, Consys, Triangle, Future Aerospace, Top Alliance, Ronbay Technology, etc.

Beijing
Panlin Capital

Investments: 88

Funds: 21

Panlin Capital is a technologically innovative early and mid-term venture capital institution focusing on biotechnology and data intelligence applications under the theme of "Technology Innovation Leads Consumption Upgrade". Panlin Capital has been focusing on independent innovation opportunities in the medical and technological fields and promoting the development of China's private economy in the long run. We look for entrepreneurs among scientists and innovators among entrepreneurs, cultivate Chinese scientific and technological innovation enterprises with capital investment, and promote the transformation of China's economic structure and the rapid development of new economy with the power of science and technology. The companies invested by Panlin Capital mainly include Bio Kangtai, Apollomics, Genfleet, Carrier Gene, Ruiyun Cold Chain, Passion Tech, etc.

Shanghai
Tech Capital

Investments: 8

Funds: 0

Tech Capital is a four-in-one platform that provides scientific and technological innovation services, incubation of scientific and technological achievements, scientific and technological investment and technology trading for hard science and technology entrepreneurs. Relying on the scientific research strength of top science institutes and universities at home and abroad and the rich industrial resources and capital market experience of advantagous capitals, Tech Capital offers professional, in-depth and comprehensive investment, incubation and financing solutions for science and technology entrepreneurs, and is committed to building a platform for the industrialization of science and technology, technicalization of industry, clustering of science and technology, technology trading and combination of industry and investment. It helps turn science and technology into productivity, uses the power of capital to build a strong science and technology nation, equips industrial entities with science and technology and capitalizes science and technology enterprises, and supports cutting-edge science and technology enterprises in all areas, from intellectual property development to initial public offerings (IPO).

Jiaxing City, Zhejiang Province
Warburg Princus

Investments: 247

Funds: 1

Warburg Pincus is a world's leading private equity investment institution, focusing on growth investment. Warburg Pincus is committed to cooperating with entrepreneurs to build enterprises with long-term sustainable value. At present, Warburg Pincus manages more than 85 billion US dollars of assets worldwide and invests in more than 250 enterprises in different industries and different stages of development. Since its establishment in 1966, Warburg Pincus has raised 21 private equity funds and 2 real estate funds, and has invested more than 106 billion US dollars in 1,000+ enterprises in over 40 countries around the world. Since entering the Chinese market in 1994, Warburg Pincus has invested a total of 15.6 billion US dollars in more than 150 domestic enterprises in various industries, making it one of the largest and most active international private equity investment institutions in China. At present, its investment focuses on six major areas, namely medical and health care, industrial technology, greater consumption, science and technology, financial services and real estate.

Beijing